# Tiara™ Transcatheter Mitral Valve Replacement Study

Study · id `cardio:ct-nct03039855` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03039855](<https://clinicaltrials.gov/study/NCT03039855>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03039855

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 157 participants.

## Technical summary

Registry record NCT03039855. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-08 (actual); primary completion 2019-12-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 157 participants (enrolled count; ClinicalTrials.gov record NCT03039855, source copy `cardio:ctgov-nct03039855-2025-09-29`, retrieved 2026-10-26)
- Started: 2017-03-08 (actual) (ClinicalTrials.gov record NCT03039855, source copy `cardio:ctgov-nct03039855-2025-09-29`, retrieved 2026-10-26)
- Primary completion: 2019-12-19 (actual) (ClinicalTrials.gov record NCT03039855, source copy `cardio:ctgov-nct03039855-2025-09-29`, retrieved 2026-10-26)
- Completion: 2024-08-06 (actual) (ClinicalTrials.gov record NCT03039855, source copy `cardio:ctgov-nct03039855-2025-09-29`, retrieved 2026-10-26)
- Countries: Germany; Israel; Italy; Netherlands; Spain; United Kingdom (ClinicalTrials.gov record NCT03039855, source copy `cardio:ctgov-nct03039855-2025-09-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03039855-2025-09-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tiara™ Transcatheter Mitral Valve Replacement Study
- Acronym: TIARA-II
- Condition: Mitral Valve Regurgitation
- Intervention (Device): TIARA valve and transapical delivery system
- Lead sponsor: Shockwave Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Shockwave Medical, Inc. (`cardio:org-shockwave-medical-inc`)

## Provenance

Content hash: 6116881be8dc1603be30e3dcceac95786ca2a454b4547aef244579736fbc9e2d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
